Author

Veronika Bachanová

University of MinnesotaORCID 0000-0002-9325-432XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Adnan MansooriD· 1 shared Akil Abid MerchantiD· 1 shared Alicia GamboaiD· 1 shared Allison HaaningiD· 1 shared Alyssa C. BouskaiD· 1 shared Amitkumar MehtaiD· 1 shared Andre Henri GoyiD· 1 shared Atqiya Fariha· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adnan MansoorORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNature CommunicationsPeer-reviewedNov 5, 2025

Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma

Sunandini Sharma, Roshia Ali, Alyssa C. Bouska…·On behalf of the North American Mantle Cell Lymphoma Project (NAMCLP)

The paper identifies prognostic biological subtypes in Mantle cell lymphoma based on genetic and transcriptomic analysis, revealing distinct molecular and immune features associated with different risk groups.

4 citations

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyBloodPeer-reviewedSep 4, 2025

Leukemia escapes immunity by imposing a Type-1 regulatory program on neoantigen-specific CD4+ T cells.

Hrishi Venkatesh, Enoc Granados Centeno, Qianyun Luo…·Sean I. Tracy

This paper shows leukemia induces neoantigen-specific CD4+ T cells to become regulatory (Tr1) cells, which suppress cytotoxic T cells and promote relapse, and repolarizing these cells to Th1 states eradicates residual disease.

4 citations

humanexperimental assay

𝕏 PostBluesky